Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

Clinical trial NCT02205489 · COMPLETED

Trial details

NCT number: NCT02205489
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2014-10-01
Primary completion: 2016-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.